Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Nov 2001 01:12 PM
RNS
Disposal
17 Oct 2001 04:12 PM
RNS
Market Maker Holding
17 Oct 2001 02:20 PM
RNS
Stmnt re press comment
16 Oct 2001 03:24 PM
RNS
Market Maker Holding
26 Sep 2001 03:50 PM
RNS
Market Maker Holding
13 Aug 2001 07:30 AM
RNS
Disposal
09 Aug 2001 05:23 PM
RNS
Re Directorate
09 Aug 2001 07:00 AM
RNS
Interim Results
20 Jul 2001 12:42 PM
RNS
Re Directorate
10 Jul 2001 09:54 AM
RNS
Disposal
19 Jun 2001 11:27 AM
RNS
Change of Name
01 Jun 2001 03:27 PM
RNS
Re Directorate - Replacement
01 Jun 2001 02:28 PM
RNS
Re Directorate
11 May 2001 04:43 PM
RNS
Additional Listing
10 May 2001 10:35 AM
RNS
Acquisition
08 May 2001 04:02 PM
RNS
Re Directorate
08 May 2001 03:41 PM
RNS
Director Shareholding
03 May 2001 04:40 PM
RNS
Additional Listing
03 May 2001 09:35 AM
RNS
Result of AGM
02 May 2001 11:00 AM
RNS
New investment
24 Apr 2001 07:00 AM
RNS
Merger Update
02 Mar 2001 12:57 PM
RNS
Prelims. Results to 31-12-00
23 Feb 2001 03:09 PM
RNS
Stmnt re Web Street Limited
01 Feb 2001 01:24 PM
RNS
Re Dynamid/ ByBox Merger
10 Jan 2001 04:22 PM
RNS
Board Changes
02 Jan 2001 10:00 AM
RNS
Director Shareholding
22 Dec 2000 01:17 PM
RNS
TaoTalk Investment ceases
18 Dec 2000 04:20 PM
RNS
Additional Listing
12 Dec 2000 07:00 AM
RNS
Re Alliance
24 Nov 2000 07:00 AM
RNS
Director Shareholding
23 Nov 2000 07:00 AM
RNS
Strategic Investment
14 Sep 2000 07:00 AM
RNS
Strategic Telecoms Investment
07 Sep 2000 07:01 AM
RNS
Strategic Alliance
22 Aug 2000 07:00 AM
RNS
Change to Board of Directors
22 Aug 2000 07:00 AM
RNS
Strategic Investment
22 Aug 2000 07:00 AM
RNS
Interim Results
16 Aug 2000 12:42 PM
RNS
Advance Notice of Interim Results
10 Aug 2000 10:15 AM
RNS
Acquisition of Interest
13 Jun 2000 10:44 AM
RNS
New Strategic Investment
15 May 2000 07:00 AM
RNS
Strategic Investment
09 May 2000 07:01 AM
RNS
£1.5m Deal Signed with Harden's Ltd
10 Apr 2000 07:01 AM
RNS
£300,000 Investment for 25% of Mailtrack Ltd
29 Feb 2000 02:58 PM
RNS
Directorate, etc

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings